{"organizations": [], "uuid": "46b70e3ac8964f93440ba5e246bd258d0dbfc700", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-rigel-intends-to-offer-sell-up-to/brief-rigel-intends-to-offer-sell-up-to-15-mln-shares-of-its-stock-in-underwritten-public-offering-idUSASC09WDI", "country": "US", "domain_rank": 408, "title": "BRIEF-Rigel Intends To Offer & Sell Up To 15 Mln Shares Of Its Stock In Underwritten Public Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T23:37:00.000+03:00", "replies_count": 0, "uuid": "46b70e3ac8964f93440ba5e246bd258d0dbfc700"}, "author": "", "url": "https://www.reuters.com/article/brief-rigel-intends-to-offer-sell-up-to/brief-rigel-intends-to-offer-sell-up-to-15-mln-shares-of-its-stock-in-underwritten-public-offering-idUSASC09WDI", "ord_in_thread": 0, "title": "BRIEF-Rigel Intends To Offer & Sell Up To 15 Mln Shares Of Its Stock In Underwritten Public Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-rigel intends to offer", "sentiment": "negative"}, {"name": "rigel pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18, 2018 / 8:40 PM / Updated 11 minutes ago BRIEF-Rigel Intends To Offer & Sell Up To 15 Mln Shares Of Its Stock In Underwritten Public Offering Reuters Staff \nApril 18 (Reuters) - Rigel Pharmaceuticals Inc: * RIGEL ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK \n* RIGEL PHARMACEUTICALS INC - INTENDS TO OFFER & SELL UP TO 15 MILLION SHARES OF ITS STOCK IN AN UNDERWRITTEN PUBLIC OFFERING \n* RIGEL PHARMACEUTICALS INC - PROCEEDS FROM OFFERING TO BE USED FOR ACTIVITIES IN CONNECTION WITH COMMERCIAL LAUNCH OF TAVALISSE IN UNITED STATES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-18T23:37:00.000+03:00", "crawled": "2018-04-18T23:55:03.022+03:00", "highlightTitle": ""}